Insights into the impact of microbiota in the treatment of nafld/nash and its potential as a biomarker for prognosis and diagnosis
Publisher
MDPI AG
Citation
Biomedicines, 9(2), 1-21. https://doi.org/10.3390/biomedicines9020145
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of chronic liver illness associated with obesity and metabolic disorders, such as hypertension, dyslipidemia, or type 2 diabetes mellit...
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
